NeuroOne Medical Technologies Corporation (NMTC)

NCM – Real Time Price. Currency in USD

4.39

+0.06 (1.39%)

At close: May 12, 2026, 4:00 PM EDT

4.50

+0.11 (2.51%)

After-hours: May 12, 2026, 5:18 PM EDT

12.03.2026

NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript

17.02.2026

NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript

06.01.2026

Best Momentum Stocks to Buy for January 6th

RIGL, CM and NMTC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 6th, 2026.

06.01.2026

New Strong Buy Stocks for January 6th

ILPT, NMTC, RIGL, RIO and BHP have been added to the Zacks Rank #1 (Strong Buy) List on January 6th, 2026.

17.12.2025

NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript

31.07.2025

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal third quarter ended June 30, 2025, before market open on August 14, 2025.

31.07.2025

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

Videos

No Data

There is no data to display

Press releases

23.07.2025

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

Patent Strengthens Intellectual Property Portfolio Surrounding Neural Probe Technologies EDEN PRAIRIE, Minn., July 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, has received a notice of allowance for a key patent from the U.S. Patent and Trademark Office (USPTO) titled, “Methods for Making Probe Devices and Related Devices”.

NeuroOne Medical Technologies Corporation (NMTC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

NeuroOne Medical Technologies Corporation (NMTC)

NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript

NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript

Best Momentum Stocks to Buy for January 6th

New Strong Buy Stocks for January 6th

NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

Videos

No Data

Press releases

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript

NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript

Best Momentum Stocks to Buy for January 6th

New Strong Buy Stocks for January 6th

NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

Videos

No Data

Press releases

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

Search stocks

NeuroOne Medical Technologies Corporation (NMTC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

NeuroOne Medical Technologies Corporation (NMTC)

NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript

NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript

Best Momentum Stocks to Buy for January 6th

New Strong Buy Stocks for January 6th

NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

Videos

No Data

Press releases

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript

NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript

Best Momentum Stocks to Buy for January 6th

New Strong Buy Stocks for January 6th

NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

Videos

No Data

Press releases

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office